Key Points
- New Rx: Adcirca, Promiseb Topical Cream, Nucynta CII, Zipsor Liquid Filled Capsules.
- New indication: Reclast Injection.
- New generics: Prednisolone Sodium Phosphate Oral Solution, Ursodiol Tablets USP, Next Choice. New OTC: A1CNow Selfcheck, Bahama
Bo's Ocean Fresh Hand Sanitizer and Tropical Creme Hand Lotion, BaBoom! Energy Spray, Crave-NX 7-day Diet Aid Spray, Glucose
Rapidspray.
RX CARE
New drugs
United Therapeutics announced that the Food and Drug Administration (FDA) has approved Adcirca (tadalafil) tablets for oral administration, with a recommended dose of 40 mg, as the first once-daily phosphodiesterase
type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH). Adcirca is indicated to improve exercise
ability in patients with multiple forms of PAH. Visit http://www.adcirca.com/ for full patient and prescribing information, or call 800-545-5979.
Promius announced the launch of Promiseb Topical Cream, a nonsteroidal cream for the treatment of seborrheic dermatitis that has shown both anti-inflammatory and antifungal properties.
The cream is intended to manage and relieve the signs and symptoms of seborrheic dermatitis such as redness, itching, and
scaling. In a randomized clinical study, this product was clinically shown to treat seborrheic dermatitis with efficacy comparable
to that of a low-potency topical corticosteroid and with fewer relapses. For more information, visit http://www.promiuspharma.com/. The PriCara division of Ortho-McNeil-Janssen announced the launch of Nucynta (tapentadol) CII, designed for patients suffering from acute pain. Nucynta CII immediate-release tablets are indicated for the relief of moderate-to-severe
acute pain in patients 18 years of age or older. This product is now available by prescription only, in 50-mg, 75-mg, and
100-mg tablets. Visit http://www.nucynta.com/ for more information.
Xanodyne has received FDA approval for Zipsor (diclofenac potassium) Liquid Filled Capsules, a new treatment option for relief of mild-to-moderate acute pain in patients 18 years of age or older. This product is the
first prescription-strength nonsteroidal anti-inflammatory drug (NSAID) for oral administration available to the U.S. market
in a liquid-filled soft gelatin capsule. Visit http://www.xanodyne.com/ for more information.
New indication
The FDA has approved Novartis' Reclast (zoledronic acid 5 mg) Injection as the first therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved
as a once-yearly infusion for the treatment of postmenopausal osteoporosis. Go to http://www.novartis.com/ for more information.
New generics
Amneal has received FDA approval to manufacture Prednisolone Sodium Phosphate Oral Solution in 15 mg/5 mL strength. This product is an AA-rated, therapeutically equivalent alternative to BioMarin's Orapred. Amneal
will sell the oral solution in two sizes — 237 ml (8 oz) and 473 ml (16 oz). This grape-flavored solution does not require
refrigeration. For more information visit http://www.amneal.com/.
Teva announced that the FDA has granted approval for the company's abbreviated new drug application (ANDA) for Ursodiol Tablets USP, 250 mg and 500 mg. These tablets are the AB-rated generic equivalents of Axcan's Urso 250 and Urso Forte, indicated for
treatment of patients with primary biliary cirrhosis. Shipment of this product has commenced. For more information, call 888-TEVA-USA.
The FDA approved Watson's generic version of the emergency contraceptive Plan B, to be marketed under the name Next Choice. The generic version will be available by prescription to women 17 years of age and younger. For more information, call 951-493-5300.
OTC
Bayer Diabetes Care announced the launch of A1CNow Selfcheck, a new A1C monitor that enables people with diabetes to check their A1C levels at home. This product, which is now available
without a prescription through online pharmacies, has an easy-to-use design and provides at-home results within five minutes
with lab accuracy. For more information, visit http://www.a1cnow.com/ or http://www.a1cselfcheck.com/.
Bahama Bo's introduces Bahama Bo's Ocean Fresh Hand Sanitizer and Bahama Bo's Tropical Creme Hand Lotion. The small, easy-to-use bottles are portable and travel well in handbags, gym bags, or carry-on luggage. Ocean Fresh Hand
Sanitizer kills 99.99 percent of germs on the hands. Tropical Creme Hand Lotion contains moisturizers and Vitamin E to keep
skin smooth and hydrated. Both the hand sanitizer and the hand lotion are packaged in a versatile 1.5-oz hanging "tottle"
bottle. For more information visit http://www.bahamabos.com/.
Generex OTC introduces BaBoom! Energy Spray, which offers a convenient boost of energy without the extra calories of traditional energy drinks, Crave-NX 7-day Diet Aid Spray, to help dieters stick to their weight loss regimens, and Glucose RapidSpray, a dietary glucose spray that helps control blood sugar levels. For more information on these products, visit http://www.baboomenergyspray.com/, http://www.crave-nx.com/, and http://www.glucoserapidspray.com/.